K2 Principal Fund’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

K2 Principal Fund’s Portfolio IMVTW Stock Details IMVTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-166,200	Closed	-$319K	–	401
2019 Q4	$332K	Buy	+166,200	New	+$337K	0.03%	260

K2 Principal Fund's IMVTW Position: Q1 2020 in Review

K2 Principal Fund sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q1 2020, closing a stake of 166,200 shares — an estimated $319K sold.

K2 Principal Fund first reported a position in IMVTW in Q4 2019 and held it in 1 quarter. The position peaked at $332K in Q4 2019. 17 funds tracked by Wall St. Rank hold IMVTW as of Q1 2020.

K2 Principal Fund reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q1 2020 after selling out during the quarter.
K2 Principal Fund sold 166,200 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q1 2020, an estimated $319K.
K2 Principal Fund first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 1 quarter.
K2 Principal Fund's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $332K in Q4 2019.
17 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q1 2020.

Based on K2 Principal Fund's 13F filing for Q1 2020, filed 15 May 2020.